Press releases | UCB
UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

20 Sep 2022

European Medicine Agency Accepts Marketing Authorization Applications for Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis

Read More
9 Sep 2022

Disposal of own shares

Read More
9 Sep 2022

ASBMR 2022: 3D modelling of hip DXA scans in postmenopausal women with osteoporosis reveals superior improvements in bone density of romosozumab versus controls

Read More
7 Sep 2022

New Three-Year BIMZELX[®]▼ (bimekizumab) Data Reinforce Long-Term Maintenance of Complete Skin Clearance in Moderate to Severe Plaque Psoriasis

Read More
1 Sep 2022

UCB Showcases Strength of the Expanding Dermatology Portfolio at the 31st EADV Congress

Read More
19 Aug 2022

Disposal of own shares

Read More

Stay up-to-date on the latest news and information from UCB